Abstract OT1-1-09: Opti-HER HEART: A prospective, multicenter, single-arm, phase II study to evaluate the safety of neoadjuvant liposomal doxorubicin plus paclitaxel, trastuzumab, and pertuzumab in patients with operable HER2-positive breast cancer.

2012 ◽  
Author(s):  
J Gavilá ◽  
A Llombart ◽  
A Guerrero ◽  
A Ruiz ◽  
V Guillem
Keyword(s):  
Breast Cancer ◽  
Phase Ii ◽  
Liposomal Doxorubicin ◽  
Phase Ii Study ◽  
Her2 Positive ◽  
Her2 Positive Breast Cancer ◽  
Positive Breast Cancer

scholarly journals Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer

2009 ◽  
Vol 15 (4) ◽  
pp. 1452-1459 ◽  
Author(s):  
Nancy U. Lin ◽  
Véronique Diéras ◽  
Devchand Paul ◽  
Dominique Lossignol ◽  
Christos Christodoulou ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Brain Metastases ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Her2 Positive ◽  
Her2 Positive Breast Cancer ◽  
Multicenter Phase ◽  
Positive Breast Cancer

scholarly journals LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases

2018 ◽  
Vol 171 (3) ◽  
pp. 637-648 ◽  
Author(s):  
Amanda E. D. Van Swearingen ◽  
Marni B. Siegel ◽  
Allison M. Deal ◽  
Maria J. Sambade ◽  
Alan Hoyle ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Brain Metastases ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Her2 Positive ◽  
Her2 Positive Breast Cancer ◽  
Breast Cancer Brain Metastases ◽  
Positive Breast Cancer

scholarly journals A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast cancer

2013 ◽  
Vol 24 (7) ◽  
pp. 1841-1847 ◽  
Author(s):  
S.M. Tolaney ◽  
J. Najita ◽  
J. Sperinde ◽  
W. Huang ◽  
W.Y. Chen ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Her2 Positive ◽  
Her2 Positive Breast Cancer ◽  
Positive Breast Cancer
Sign in / Sign up

Export Citation Format

Share Document